These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39063189)

  • 1. Transcriptome Analysis of Mesenchymal Progenitor Cells Revealed Molecular Insights into Metabolic Dysfunction and Inflammation in Polycystic Ovary Syndrome.
    Huang MC; Chen PL; Hsu CL
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
    Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
    Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and adipocyte differentiation of polycystic ovary syndrome-derived induced pluripotent stem cells.
    Yang S; Ding S; Jiang X; Sun B; Xu Q
    Cell Prolif; 2016 Jun; 49(3):352-61. PubMed ID: 27108524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome.
    Su NJ; Ma J; Feng DF; Zhou S; Li ZT; Zhou WP; Deng H; Liang JY; Yang XH; Zhang YM; Liu FH; Zhang L
    Gynecol Endocrinol; 2018 Jul; 34(7):584-588. PubMed ID: 29262729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
    Piltonen TT; Chen J; Erikson DW; Spitzer TL; Barragan F; Rabban JT; Huddleston H; Irwin JC; Giudice LC
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3765-75. PubMed ID: 23824412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.
    Chazenbalk G; Chen YH; Heneidi S; Lee JM; Pall M; Chen YD; Azziz R
    J Clin Endocrinol Metab; 2012 May; 97(5):E765-70. PubMed ID: 22344199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling.
    Huang CC; Chen MJ; Lan CW; Wu CE; Huang MC; Kuo HC; Ho HN
    Fertil Steril; 2019 Sep; 112(3):594-607.e12. PubMed ID: 31277818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential genes in adipocytes induced from polycystic and non-polycystic ovary syndrome-derived human embryonic stem cells.
    Wang F; Liu WW; Chen XM; Kong HJ; Li J; Sun YP
    Syst Biol Reprod Med; 2014 Jun; 60(3):136-42. PubMed ID: 24517280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell sequencing provides insights into the landscape of ovary in PCOS and alterations induced by CUMS.
    Zuo W; Liu X; Chen J; Zuo W; Yin Y; Nie X; Tang P; Huang Y; Yu Q; Hu Q; Zhou J; Tan Y; Huang X; Ren Q
    Am J Physiol Endocrinol Metab; 2023 Oct; 325(4):E346-E362. PubMed ID: 37584608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).
    Khatun M; Lundin K; Naillat F; Loog L; Saarela U; Tuuri T; Salumets A; Piltonen TT; Tapanainen JS
    Stem Cell Rev Rep; 2024 Jan; 20(1):67-87. PubMed ID: 37768523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.
    Lan CW; Chen MJ; Tai KY; Yu DC; Yang YC; Jan PS; Yang YS; Chen HF; Ho HN
    Sci Rep; 2015 Oct; 5():14994. PubMed ID: 26459919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.
    Adams J; Liu Z; Ren YA; Wun WS; Zhou W; Kenigsberg S; Librach C; Valdes C; Gibbons W; Richards J
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3459-68. PubMed ID: 27228368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling.
    Fu Y; Zhang M; Sui B; Yuan F; Zhang W; Weng Y; Xiang L; Li C; Shao L; You Y; Mao X; Zeng H; Chen D; Zhang M; Shi S; Hu X
    Theranostics; 2024; 14(8):3385-3403. PubMed ID: 38855175
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis.
    Yang D; Li N; Ma A; Dai F; Zheng Y; Hu X; Wang Y; Xian S; Zhang L; Yuan M; Liu S; Deng Z; Yang Y; Cheng Y
    Reprod Sci; 2021 May; 28(5):1353-1361. PubMed ID: 33067753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS).
    Zhao Y; Tao M; Wei M; Du S; Wang H; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3804-3813. PubMed ID: 31549864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an induced pluripotent stem cell line AMUFAHi002-A from polycystic ovary syndrome patient.
    Jiang X; Hu R; Li C; Xu X; Zhou P; Cao Y; Wang J; Wei Z
    Stem Cell Res; 2022 Aug; 63():102875. PubMed ID: 35914484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALG2 inhibits the epithelial-to-mesenchymal transition and stemness of ovarian granulosa cells through the Wnt/β-catenin signaling pathway in polycystic ovary syndrome.
    Zheng Q; Liu M; Fu J
    Reprod Biol; 2022 Dec; 22(4):100706. PubMed ID: 36327672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.